The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $816,735 in first-year total cost, median $816,735.
Most frequent study sections
- ZAG1-ZIJ-3(A2)1
Most frequent institutions
- UNIV OF MASSACHUSETTS MED SCH WORCESTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Controlling And Stopping Cascades leading to Adverse Drug Effects Study in Alzheimer's Disease (CASCADES-AD)1R56AG061813-01 | GURWITZ, JERRY H | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $816,735 | ZAG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.